Correlation Between Trevi Therapeutics and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Xilio Development, you can compare the effects of market volatilities on Trevi Therapeutics and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Xilio Development.
Diversification Opportunities for Trevi Therapeutics and Xilio Development
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Trevi and Xilio is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Xilio Development go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Xilio Development
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.75 times more return on investment than Xilio Development. However, Trevi Therapeutics is 1.34 times less risky than Xilio Development. It trades about 0.05 of its potential returns per unit of risk. Xilio Development is currently generating about 0.01 per unit of risk. If you would invest 179.00 in Trevi Therapeutics on September 13, 2024 and sell it today you would earn a total of 181.00 from holding Trevi Therapeutics or generate 101.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Trevi Therapeutics vs. Xilio Development
Performance |
| Timeline |
| Trevi Therapeutics |
| Xilio Development |
Trevi Therapeutics and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trevi Therapeutics and Xilio Development
The main advantage of trading using opposite Trevi Therapeutics and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |